Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOT-MS: Discontinuing DMTs in Stable MS
NCT04260711Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2020
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Randomised, single-blind trial in multiple sclerosis (MS) and Secondary Progressive Multiple Sclerosis (SPMS) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Clinical relapses at 2 years and New lesions on MRI-brain at 2 years. Status: unknown.
02
Conditions
multiple sclerosis (MS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT04260711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04260711.